Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated:  1/10/2018
Alcohol and Drug Recovery Centers, Inc.
mi
from
Hartford, CT
CM Treatment for Alcohol Dependence Using New Technology
CM Treatment for Alcohol Dependence Using New Technology
Status: Enrolling
Updated: 1/10/2018
Alcohol and Drug Recovery Centers, Inc.
mi
from
Hartford, CT
Click here to add this to my saved trials
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
Status: Enrolling
Updated:  1/10/2018
3-C Institute for Social Development, dba 3C Institute
mi
from
Durham, NC
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
Status: Enrolling
Updated: 1/10/2018
3-C Institute for Social Development, dba 3C Institute
mi
from
Durham, NC
Click here to add this to my saved trials
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)
Improving PTSD Service Delivery for Veterans With Severe Mental Illness
Status: Enrolling
Updated:  1/11/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)
Improving PTSD Service Delivery for Veterans With Severe Mental Illness
Status: Enrolling
Updated: 1/11/2018
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials
Oxytocin and CBSST for People With Schizophrenia
Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
Status: Enrolling
Updated:  1/11/2018
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Oxytocin and CBSST for People With Schizophrenia
Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
Status: Enrolling
Updated: 1/11/2018
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oxytocin and CBSST for People With Schizophrenia
Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
Status: Enrolling
Updated:  1/11/2018
University of California, San Diego
mi
from
San Diego, CA
Oxytocin and CBSST for People With Schizophrenia
Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
Status: Enrolling
Updated: 1/11/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Status: Enrolling
Updated:  1/11/2018
Duke University
mi
from
Durham, NC
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Status: Enrolling
Updated: 1/11/2018
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Status: Enrolling
Updated:  1/11/2018
Univ of Washington
mi
from
Seattle, WA
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Mobile Mindfulness to Improve Psychological Distress After Critical Illness
Status: Enrolling
Updated: 1/11/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia
Response Prevention or Response Permission? A Randomized Controlled Trial of the "Judicious Use of Safety Behaviors" During Exposure Therapy (Institutional Review Board Title: Overcome Your Spider Phobia)
Status: Enrolling
Updated:  1/11/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia
Response Prevention or Response Permission? A Randomized Controlled Trial of the "Judicious Use of Safety Behaviors" During Exposure Therapy (Institutional Review Board Title: Overcome Your Spider Phobia)
Status: Enrolling
Updated: 1/11/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Delirium in Persons With Dementia
Delirium in Persons With Dementia
Status: Enrolling
Updated:  1/11/2018
Mount Nittany Medical Center
mi
from
State College, PA
Delirium in Persons With Dementia
Delirium in Persons With Dementia
Status: Enrolling
Updated: 1/11/2018
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Status: Enrolling
Updated:  1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
Status: Enrolling
Updated: 1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Status: Enrolling
Updated:  1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
Status: Enrolling
Updated: 1/12/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Treatment of Refractory Schizophrenia With Riluzole
Neuroprotective Treatment of Refractory Schizophrenia With Riluzole 01T-432
Status: Enrolling
Updated:  1/12/2018
Yale Department of Psychiatry
mi
from
New Haven, CT
Treatment of Refractory Schizophrenia With Riluzole
Neuroprotective Treatment of Refractory Schizophrenia With Riluzole 01T-432
Status: Enrolling
Updated: 1/12/2018
Yale Department of Psychiatry
mi
from
New Haven, CT
Click here to add this to my saved trials
Memantine in the Treatment of Kleptomania
Memantine Treatment of Kleptomania: An Open-Label Study
Status: Enrolling
Updated:  1/12/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Memantine in the Treatment of Kleptomania
Memantine Treatment of Kleptomania: An Open-Label Study
Status: Enrolling
Updated: 1/12/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
Hamden Public Schools
mi
from
Hamden, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Hamden Public Schools
mi
from
Hamden, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
Department of Psychiatry, Yale University
mi
from
New Haven, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Department of Psychiatry, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
Yale Child Study Center
mi
from
New Haven, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
Capital Medical University
mi
from
Beijing,
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Capital Medical University
mi
from
Beijing,
Click here to add this to my saved trials
Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness
Increasing Health Care Choices and Improving Health Outcomes Among Persons With Serious Mental Illness
Status: Enrolling
Updated:  1/12/2018
CT Mental Health Center
mi
from
New Haven, CT
Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness
Increasing Health Care Choices and Improving Health Outcomes Among Persons With Serious Mental Illness
Status: Enrolling
Updated: 1/12/2018
CT Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness
Increasing Health Care Choices and Improving Health Outcomes Among Persons With Serious Mental Illness
Status: Enrolling
Updated:  1/12/2018
Yale University Program for Recovery and Community Health
mi
from
New Haven, CT
Project Wellness Enhancement: Increasing Health Care Choice and Outcomes for People With Mental Illness
Increasing Health Care Choices and Improving Health Outcomes Among Persons With Serious Mental Illness
Status: Enrolling
Updated: 1/12/2018
Yale University Program for Recovery and Community Health
mi
from
New Haven, CT
Click here to add this to my saved trials
Iloperidone in Mixed States of Bipolar Disorder
Open Label Study of Iloperidone (IL) as Adjunctive Treatment in Mixed States (MS) of Bipolar Disorder (BD)
Status: Enrolling
Updated:  1/12/2018
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
Iloperidone in Mixed States of Bipolar Disorder
Open Label Study of Iloperidone (IL) as Adjunctive Treatment in Mixed States (MS) of Bipolar Disorder (BD)
Status: Enrolling
Updated: 1/12/2018
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Combining Behavioral Treatment With Agonist Maintenance - 1
Combining Behavioral Treatment With Agonist Maintenance
Status: Enrolling
Updated:  1/12/2018
APT Residential Services Division
mi
from
New Haven, CT
Combining Behavioral Treatment With Agonist Maintenance - 1
Combining Behavioral Treatment With Agonist Maintenance
Status: Enrolling
Updated: 1/12/2018
APT Residential Services Division
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients
Levetiracetam (Keppra) Treatment for Cocaine Dependence in Methadone-Maintained Patients
Status: Enrolling
Updated:  1/12/2018
Va Ct Healthcare System
mi
from
West Haven, CT
Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients
Levetiracetam (Keppra) Treatment for Cocaine Dependence in Methadone-Maintained Patients
Status: Enrolling
Updated: 1/12/2018
Va Ct Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  1/15/2018
Clinical Research Facility
mi
from
Nashville, TN
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 1/15/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  1/15/2018
Clinical Research Facility
mi
from
Dallas, TX
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 1/15/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated:  1/15/2018
Clinical Research Facility
mi
from
Atlanta, GA
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
A Phase 1, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB047986 in Subjects With Advanced Malignancies
Status: Enrolling
Updated: 1/15/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Cocaine Withdrawal and Pharmacotherapy Response
Cocaine Withdrawal and Pharmacotherapy Response
Status: Enrolling
Updated:  1/16/2018
Veterans Hospital
mi
from
West Haven, CT
Cocaine Withdrawal and Pharmacotherapy Response
Cocaine Withdrawal and Pharmacotherapy Response
Status: Enrolling
Updated: 1/16/2018
Veterans Hospital
mi
from
West Haven, CT
Click here to add this to my saved trials
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
Status: Enrolling
Updated:  1/16/2018
Clinical Research Centers at Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
Intravenous Ketamine in the Treatment of Obsessive-Compulsive Disorder
Status: Enrolling
Updated: 1/16/2018
Clinical Research Centers at Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder
Status: Enrolling
Updated:  1/16/2018
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
Effect of Oxytocin on Pro-Social Behavior in Social Anxiety Disorder
Status: Enrolling
Updated: 1/16/2018
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated:  1/16/2018
Collington Square Elementary Middle School
mi
from
Baltimore, MD
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated: 1/16/2018
Collington Square Elementary Middle School
mi
from
Baltimore, MD
Click here to add this to my saved trials
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated:  1/16/2018
Commodore John Rodgers Elementary Middle School
mi
from
Baltimore, MD
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated: 1/16/2018
Commodore John Rodgers Elementary Middle School
mi
from
Baltimore, MD
Click here to add this to my saved trials
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated:  1/16/2018
Tench Tilghman Elementary Middle School
mi
from
Baltimore, MD
D-Stress Baltimore: School-based Mindfulness Instruction
D-Stress Baltimore: School-based Mindfulness Instruction for Primary Prevention of Mental Health and Behavioral Problems in Middle School
Status: Enrolling
Updated: 1/16/2018
Tench Tilghman Elementary Middle School
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
Status: Enrolling
Updated:  1/16/2018
University of California, Irvine/Child Development Center
mi
from
Irvine, CA
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
Status: Enrolling
Updated: 1/16/2018
University of California, Irvine/Child Development Center
mi
from
Irvine, CA
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Baltimore VA Medical Center
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Baltimore VA Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Keypoint Health System
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Keypoint Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Sheppard Pratt Health System
mi
from
Baltimore, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Sheppard Pratt Health System
mi
from
Baltimore, MD
Click here to add this to my saved trials
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated:  1/16/2018
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP)
mi
from
Catonsville, MD
The Effects of Rimonabant, on Weight and Metabolic Risk Factors
The Effects of the Cannabinoid-1 Receptor Antagonist, Rimonabant, on Weight and Metabolic Risk Factors in People With Schizophrenia
Status: Enrolling
Updated: 1/16/2018
Maryland Psychiatric Research Center (MPRC) Outpatient Research Program (ORP); the MPRC Treatment Research Program (TRP)
mi
from
Catonsville, MD
Click here to add this to my saved trials
Treatment of Social Phobia
Treatment of Social Phobia: Mediators And Moderators
Status: Enrolling
Updated:  1/16/2018
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Treatment of Social Phobia
Treatment of Social Phobia: Mediators And Moderators
Status: Enrolling
Updated: 1/16/2018
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Drug Treatment for Alcoholics With Bipolar Disorder
Efficacy of Valproate Maintenance in Bipolar Alcoholics
Status: Enrolling
Updated:  1/16/2018
Department of Psychiatry, Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Drug Treatment for Alcoholics With Bipolar Disorder
Efficacy of Valproate Maintenance in Bipolar Alcoholics
Status: Enrolling
Updated: 1/16/2018
Department of Psychiatry, Western Psychiatric Institute and Clinic of the University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy
Identifying Biomarkers That Distinguish Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury Using Advanced Magnetic Resonance Spectroscopy
Status: Enrolling
Updated:  1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy
Identifying Biomarkers That Distinguish Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury Using Advanced Magnetic Resonance Spectroscopy
Status: Enrolling
Updated: 1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Fish Oil vs. Placebo on Subjective Effects of Alcohol
Effect of Fish Oil vs. Placebo on Subjective Effects of Alcohol in Healthy Humans
Status: Enrolling
Updated:  1/16/2018
VA Connecticut Healtcare System
mi
from
West Haven, CT
Fish Oil vs. Placebo on Subjective Effects of Alcohol
Effect of Fish Oil vs. Placebo on Subjective Effects of Alcohol in Healthy Humans
Status: Enrolling
Updated: 1/16/2018
VA Connecticut Healtcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Varenicline for Methamphetamine Dependence
Varenicline for Methamphetamine Dependence: Phase II Clinical Trial
Status: Enrolling
Updated:  1/17/2018
UCLA Vine Street Clinic
mi
from
Los Angeles, CA
Varenicline for Methamphetamine Dependence
Varenicline for Methamphetamine Dependence: Phase II Clinical Trial
Status: Enrolling
Updated: 1/17/2018
UCLA Vine Street Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD): an Functional Magnetic Resonance Imaging(fMRI) Study of Brain Activation Pre and Post Treatment
Status: Enrolling
Updated:  1/17/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD): an Functional Magnetic Resonance Imaging(fMRI) Study of Brain Activation Pre and Post Treatment
Status: Enrolling
Updated: 1/17/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Using Mobile Technology to Enhance Multisystemic Therapy (MST) Outcomes
Phase I - Using Mobile Technology to Enhance MST Outcomes (VillageWhere)
Status: Enrolling
Updated:  1/17/2018
Evidence-Based Practice Institute
mi
from
Seattle, WA
Using Mobile Technology to Enhance Multisystemic Therapy (MST) Outcomes
Phase I - Using Mobile Technology to Enhance MST Outcomes (VillageWhere)
Status: Enrolling
Updated: 1/17/2018
Evidence-Based Practice Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
A Randomized, Double-blind Study of Ketamine / Dexmedetomidine vs. Placebo / Dexmedetomidine as Adjunctive Therapies for Severe Alcohol Withdrawal
Status: Enrolling
Updated:  1/17/2018
University of Colorado Hospital
mi
from
Aurora, CO
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal
A Randomized, Double-blind Study of Ketamine / Dexmedetomidine vs. Placebo / Dexmedetomidine as Adjunctive Therapies for Severe Alcohol Withdrawal
Status: Enrolling
Updated: 1/17/2018
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
Status: Enrolling
Updated:  1/17/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
Status: Enrolling
Updated: 1/17/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
Status: Enrolling
Updated:  1/17/2018
Mt. Sinai Medical Center
mi
from
New York, NY
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder
Status: Enrolling
Updated: 1/17/2018
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Stanford University
mi
from
Stanford, CA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Massachusetts General Hospital
mi
from
Boston, MA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated:  1/17/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder
Lithium Use for Bipolar Disorder (LiTMUS): A Randomized Controlled Effectiveness Trial
Status: Enrolling
Updated: 1/17/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials